View in EDS

Gadolinium Distribution in Cerebrospinal Fluid after Administration of a Gadolinium-based MR Contrast Agent in Humans.

Saved in:
Bibliographic Details
Title: Gadolinium Distribution in Cerebrospinal Fluid after Administration of a Gadolinium-based MR Contrast Agent in Humans.
Authors: Berger F; From the Departments of Radiology (F.B., R.A.K.H., T.N.) and Internal Medicine (H.R.S., J.H.B.), Kantonsspital Baden AG, Im Ergel 1, 5401 Baden, Switzerland; Department of Forensic Medicine and Imaging (F.B., M.J.T.) and Department of Forensic Pharmacology and Toxicology (M.P., T.K.), Zurich Institute of Forensic Medicine, University of Zurich, Switzerland; and Guerbet Contrast Media Company, Zurich, Switzerland (J.M.F.)., Kubik-Huch RA; From the Departments of Radiology (F.B., R.A.K.H., T.N.) and Internal Medicine (H.R.S., J.H.B.), Kantonsspital Baden AG, Im Ergel 1, 5401 Baden, Switzerland; Department of Forensic Medicine and Imaging (F.B., M.J.T.) and Department of Forensic Pharmacology and Toxicology (M.P., T.K.), Zurich Institute of Forensic Medicine, University of Zurich, Switzerland; and Guerbet Contrast Media Company, Zurich, Switzerland (J.M.F.)., Niemann T; From the Departments of Radiology (F.B., R.A.K.H., T.N.) and Internal Medicine (H.R.S., J.H.B.), Kantonsspital Baden AG, Im Ergel 1, 5401 Baden, Switzerland; Department of Forensic Medicine and Imaging (F.B., M.J.T.) and Department of Forensic Pharmacology and Toxicology (M.P., T.K.), Zurich Institute of Forensic Medicine, University of Zurich, Switzerland; and Guerbet Contrast Media Company, Zurich, Switzerland (J.M.F.)., Schmid HR; From the Departments of Radiology (F.B., R.A.K.H., T.N.) and Internal Medicine (H.R.S., J.H.B.), Kantonsspital Baden AG, Im Ergel 1, 5401 Baden, Switzerland; Department of Forensic Medicine and Imaging (F.B., M.J.T.) and Department of Forensic Pharmacology and Toxicology (M.P., T.K.), Zurich Institute of Forensic Medicine, University of Zurich, Switzerland; and Guerbet Contrast Media Company, Zurich, Switzerland (J.M.F.)., Poetzsch M; From the Departments of Radiology (F.B., R.A.K.H., T.N.) and Internal Medicine (H.R.S., J.H.B.), Kantonsspital Baden AG, Im Ergel 1, 5401 Baden, Switzerland; Department of Forensic Medicine and Imaging (F.B., M.J.T.) and Department of Forensic Pharmacology and Toxicology (M.P., T.K.), Zurich Institute of Forensic Medicine, University of Zurich, Switzerland; and Guerbet Contrast Media Company, Zurich, Switzerland (J.M.F.)., Froehlich JM; From the Departments of Radiology (F.B., R.A.K.H., T.N.) and Internal Medicine (H.R.S., J.H.B.), Kantonsspital Baden AG, Im Ergel 1, 5401 Baden, Switzerland; Department of Forensic Medicine and Imaging (F.B., M.J.T.) and Department of Forensic Pharmacology and Toxicology (M.P., T.K.), Zurich Institute of Forensic Medicine, University of Zurich, Switzerland; and Guerbet Contrast Media Company, Zurich, Switzerland (J.M.F.)., Beer JH; From the Departments of Radiology (F.B., R.A.K.H., T.N.) and Internal Medicine (H.R.S., J.H.B.), Kantonsspital Baden AG, Im Ergel 1, 5401 Baden, Switzerland; Department of Forensic Medicine and Imaging (F.B., M.J.T.) and Department of Forensic Pharmacology and Toxicology (M.P., T.K.), Zurich Institute of Forensic Medicine, University of Zurich, Switzerland; and Guerbet Contrast Media Company, Zurich, Switzerland (J.M.F.)., Thali MJ; From the Departments of Radiology (F.B., R.A.K.H., T.N.) and Internal Medicine (H.R.S., J.H.B.), Kantonsspital Baden AG, Im Ergel 1, 5401 Baden, Switzerland; Department of Forensic Medicine and Imaging (F.B., M.J.T.) and Department of Forensic Pharmacology and Toxicology (M.P., T.K.), Zurich Institute of Forensic Medicine, University of Zurich, Switzerland; and Guerbet Contrast Media Company, Zurich, Switzerland (J.M.F.)., Kraemer T; From the Departments of Radiology (F.B., R.A.K.H., T.N.) and Internal Medicine (H.R.S., J.H.B.), Kantonsspital Baden AG, Im Ergel 1, 5401 Baden, Switzerland; Department of Forensic Medicine and Imaging (F.B., M.J.T.) and Department of Forensic Pharmacology and Toxicology (M.P., T.K.), Zurich Institute of Forensic Medicine, University of Zurich, Switzerland; and Guerbet Contrast Media Company, Zurich, Switzerland (J.M.F.).
Source: Radiology [Radiology] 2018 Sep; Vol. 288 (3), pp. 703-709. Date of Electronic Publication: 2018 May 08.
Publication Type: Journal Article
Journal Info: Publisher: Radiological Society of North America Country of Publication: United States NLM ID: 0401260 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-1315 (Electronic) Linking ISSN: 00338419 NLM ISO Abbreviation: Radiology Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 29737953
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Gadolinium Distribution in Cerebrospinal Fluid after Administration of a Gadolinium-based MR Contrast Agent in Humans.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Berger+F%22">Berger F</searchLink>; From the Departments of Radiology (F.B., R.A.K.H., T.N.) and Internal Medicine (H.R.S., J.H.B.), Kantonsspital Baden AG, Im Ergel 1, 5401 Baden, Switzerland; Department of Forensic Medicine and Imaging (F.B., M.J.T.) and Department of Forensic Pharmacology and Toxicology (M.P., T.K.), Zurich Institute of Forensic Medicine, University of Zurich, Switzerland; and Guerbet Contrast Media Company, Zurich, Switzerland (J.M.F.).<br /><searchLink fieldCode="AU" term="%22Kubik-Huch+RA%22">Kubik-Huch RA</searchLink>; From the Departments of Radiology (F.B., R.A.K.H., T.N.) and Internal Medicine (H.R.S., J.H.B.), Kantonsspital Baden AG, Im Ergel 1, 5401 Baden, Switzerland; Department of Forensic Medicine and Imaging (F.B., M.J.T.) and Department of Forensic Pharmacology and Toxicology (M.P., T.K.), Zurich Institute of Forensic Medicine, University of Zurich, Switzerland; and Guerbet Contrast Media Company, Zurich, Switzerland (J.M.F.).<br /><searchLink fieldCode="AU" term="%22Niemann+T%22">Niemann T</searchLink>; From the Departments of Radiology (F.B., R.A.K.H., T.N.) and Internal Medicine (H.R.S., J.H.B.), Kantonsspital Baden AG, Im Ergel 1, 5401 Baden, Switzerland; Department of Forensic Medicine and Imaging (F.B., M.J.T.) and Department of Forensic Pharmacology and Toxicology (M.P., T.K.), Zurich Institute of Forensic Medicine, University of Zurich, Switzerland; and Guerbet Contrast Media Company, Zurich, Switzerland (J.M.F.).<br /><searchLink fieldCode="AU" term="%22Schmid+HR%22">Schmid HR</searchLink>; From the Departments of Radiology (F.B., R.A.K.H., T.N.) and Internal Medicine (H.R.S., J.H.B.), Kantonsspital Baden AG, Im Ergel 1, 5401 Baden, Switzerland; Department of Forensic Medicine and Imaging (F.B., M.J.T.) and Department of Forensic Pharmacology and Toxicology (M.P., T.K.), Zurich Institute of Forensic Medicine, University of Zurich, Switzerland; and Guerbet Contrast Media Company, Zurich, Switzerland (J.M.F.).<br /><searchLink fieldCode="AU" term="%22Poetzsch+M%22">Poetzsch M</searchLink>; From the Departments of Radiology (F.B., R.A.K.H., T.N.) and Internal Medicine (H.R.S., J.H.B.), Kantonsspital Baden AG, Im Ergel 1, 5401 Baden, Switzerland; Department of Forensic Medicine and Imaging (F.B., M.J.T.) and Department of Forensic Pharmacology and Toxicology (M.P., T.K.), Zurich Institute of Forensic Medicine, University of Zurich, Switzerland; and Guerbet Contrast Media Company, Zurich, Switzerland (J.M.F.).<br /><searchLink fieldCode="AU" term="%22Froehlich+JM%22">Froehlich JM</searchLink>; From the Departments of Radiology (F.B., R.A.K.H., T.N.) and Internal Medicine (H.R.S., J.H.B.), Kantonsspital Baden AG, Im Ergel 1, 5401 Baden, Switzerland; Department of Forensic Medicine and Imaging (F.B., M.J.T.) and Department of Forensic Pharmacology and Toxicology (M.P., T.K.), Zurich Institute of Forensic Medicine, University of Zurich, Switzerland; and Guerbet Contrast Media Company, Zurich, Switzerland (J.M.F.).<br /><searchLink fieldCode="AU" term="%22Beer+JH%22">Beer JH</searchLink>; From the Departments of Radiology (F.B., R.A.K.H., T.N.) and Internal Medicine (H.R.S., J.H.B.), Kantonsspital Baden AG, Im Ergel 1, 5401 Baden, Switzerland; Department of Forensic Medicine and Imaging (F.B., M.J.T.) and Department of Forensic Pharmacology and Toxicology (M.P., T.K.), Zurich Institute of Forensic Medicine, University of Zurich, Switzerland; and Guerbet Contrast Media Company, Zurich, Switzerland (J.M.F.).<br /><searchLink fieldCode="AU" term="%22Thali+MJ%22">Thali MJ</searchLink>; From the Departments of Radiology (F.B., R.A.K.H., T.N.) and Internal Medicine (H.R.S., J.H.B.), Kantonsspital Baden AG, Im Ergel 1, 5401 Baden, Switzerland; Department of Forensic Medicine and Imaging (F.B., M.J.T.) and Department of Forensic Pharmacology and Toxicology (M.P., T.K.), Zurich Institute of Forensic Medicine, University of Zurich, Switzerland; and Guerbet Contrast Media Company, Zurich, Switzerland (J.M.F.).<br /><searchLink fieldCode="AU" term="%22Kraemer+T%22">Kraemer T</searchLink>; From the Departments of Radiology (F.B., R.A.K.H., T.N.) and Internal Medicine (H.R.S., J.H.B.), Kantonsspital Baden AG, Im Ergel 1, 5401 Baden, Switzerland; Department of Forensic Medicine and Imaging (F.B., M.J.T.) and Department of Forensic Pharmacology and Toxicology (M.P., T.K.), Zurich Institute of Forensic Medicine, University of Zurich, Switzerland; and Guerbet Contrast Media Company, Zurich, Switzerland (J.M.F.).
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220401260%22">Radiology</searchLink> [Radiology] 2018 Sep; Vol. 288 (3), pp. 703-709. <i>Date of Electronic Publication: </i>2018 May 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Radiological+Society+of+North+America%22">Radiological Society of North America </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0401260 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-1315 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200338419%22">00338419 </searchLink><i>NLM ISO Abbreviation: </i>Radiology <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29737953
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1148/radiol.2018171829
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 703
    Titles:
      – TitleFull: Gadolinium Distribution in Cerebrospinal Fluid after Administration of a Gadolinium-based MR Contrast Agent in Humans.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Berger F
      – PersonEntity:
          Name:
            NameFull: Kubik-Huch RA
      – PersonEntity:
          Name:
            NameFull: Niemann T
      – PersonEntity:
          Name:
            NameFull: Schmid HR
      – PersonEntity:
          Name:
            NameFull: Poetzsch M
      – PersonEntity:
          Name:
            NameFull: Froehlich JM
      – PersonEntity:
          Name:
            NameFull: Beer JH
      – PersonEntity:
          Name:
            NameFull: Thali MJ
      – PersonEntity:
          Name:
            NameFull: Kraemer T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2018 Sep
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-electronic
              Value: 1527-1315
          Numbering:
            – Type: volume
              Value: 288
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Radiology
              Type: main
ResultId 1